Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory M Cote

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
BMC Cancer|November 7, 2014
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapyEdwin Choy, James E Butrynski, David C Harmon, et al.
Cancer|December 25, 2014
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcomaEdwin Choy, Yael Flamand, Sriram Balasubramanian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 16, 2022
Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomasWalter Banfield, Myrsini Ioakeim-Ioannidou, Saveli Goldberg, et al.
The Oncologist|March 8, 2018
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced CancersAnthony Tolcher, Keith Flaherty, Geoffrey I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid TumorsGregory M Cote, Bose S Kochupurakkal, Khanh Do, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L Haddox, Michael J Nathenson, Emanuele Mazzola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2020
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced ChondrosarcomaWilliam D Tap, Victor M Villalobos, Gregory M Cote, et al.
Communications Biology|March 9, 2022
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcomaChristopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
The American Journal of Surgical Pathology|June 11, 2021
Clinical Utility of Anchored Multiplex Solid Fusion Assay for Diagnosis of Bone and Soft Tissue TumorsIvan Chebib, Martin S Taylor, Valentina Nardi, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
BMC Cancer|November 7, 2014
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapyEdwin Choy, James E Butrynski, David C Harmon, et al.
Cancer|December 25, 2014
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcomaEdwin Choy, Yael Flamand, Sriram Balasubramanian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 16, 2022
Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomasWalter Banfield, Myrsini Ioakeim-Ioannidou, Saveli Goldberg, et al.
The Oncologist|March 8, 2018
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced CancersAnthony Tolcher, Keith Flaherty, Geoffrey I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid TumorsGregory M Cote, Bose S Kochupurakkal, Khanh Do, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L Haddox, Michael J Nathenson, Emanuele Mazzola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2020
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced ChondrosarcomaWilliam D Tap, Victor M Villalobos, Gregory M Cote, et al.
Communications Biology|March 9, 2022
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcomaChristopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
The American Journal of Surgical Pathology|June 11, 2021
Clinical Utility of Anchored Multiplex Solid Fusion Assay for Diagnosis of Bone and Soft Tissue TumorsIvan Chebib, Martin S Taylor, Valentina Nardi, et al.
Pageof 10